Blonde2 Laydown 2

Lanluma celebrates one year in the market

${ weeks } weeks

${ days } days

${ hours } hours

${ minutes } minutes

${ seconds } seconds

LANLUMA

Is a collagen stimulating injectable filler for the face and body that contours, reshapes and activates the production of natural collagen, so patients can wear their new-found confidence.

Lanluma marks 1st Year in the Aesthetic Market #LanlumaYearOne

LANLUMA

Since we launched last year*, Healthcare Professionals across Europe and the UK have performed more than 1500 Lanluma Buttock(s) treatments**, and over 2000 Lanluma treatments** on other face and body areas.

Discover the Before & After pictures of Lanluma patients and be wowed by beautiful results.

Actual patient, individual results may vary.

Lanluma Before And After (5)

LANLUMA

Contact us and get started with Lanluma

Model is not an actual patient.

Lanluma Year Anniversary

Happy birthday Lanluma!

* period: February 2021 - January 2022.

** estimated number of treatments performed based on Sinclair sales data.

NOTICE

Content regarding Lanluma® is not intended for patients and healthcare professionals based in Germany and Spain.

Die Inhalte zu Lanluma® sind nicht für Patienten und Ärzte mit Sitz in Deutschland bestimmt.

El contenido relacionado con Lanluma® no está destinado a pacientes y profesionales sanitarios con sede en España.

NOTICE

Content regarding Lanluma® is not intended for patients and healthcare professionals based in Germany and Spain.

Die Inhalte zu Lanluma® sind nicht für Patienten und Ärzte mit Sitz in Deutschland bestimmt.

El contenido relacionado con Lanluma® no está destinado a pacientes y profesionales sanitarios con sede en España.

INDICATION

Lanluma is a poly-L-lactic acid implant suitable for increasing the volume of depressed areas, particularly to correct skin depressions.

IMPORTANT SAFETY CONSIDERATIONS

Like all procedures of this type there is a possibility of adverse events, although not everybody experiences them. These adverse events include but are not limited to infection, minimal acute inflammatory tissue reaction (redness, swelling, rash, oedema, erythema, lumps/nodules etc.), pain (which may be temporary or persistent in nature), transient haematoma or bruising. For a full list consult Instructions for Use.

The onset of any side effect must be reported immediately. Please contact the local Sinclair representative or authorised Lanluma distributor. Alternatively send the details to Sinclair on: quality@sinclair.com

For a full list of contraindications, warnings and precautions for this product please visit https://www.sinclairpharma.com/eifu for copy of the Product Instructions for Use.